Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

30.39 +2.06 (+7.27%)
Streaming Delayed Price Updated: 9:44 AM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Tonix Pharmaceuticals Holding Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Nike, Micron And 3 Stocks To Watch Heading Into Thursday
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Peering Into Tonix Pharmaceuticals's Recent Short Interest
Via Benzinga
7 F-Rated Penny Stocks to Avoid This June
These F-rated penny stocks have the lowest ratings from the Portfolio Grader based on factors like earnings, growth and momentum. 
Via InvestorPlace
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024
Discover top strong buy penny stocks, poised for impressive gains as market indices climb, offering unique opportunities. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
This Biopharma Stock Is Trading 23% Higher In Pre-Market After Wrapping Up $4M Public Offering
The public offering included 1,199,448 shares of common stock and pre-funded warrants to purchase up to 2,568,110 shares of common stock. 
Via Benzinga
Crude Oil Moves Higher; Vera Bradley Shares Slide
Via Benzinga
Exposures Fossil Fuels
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Nasdaq Jumps 300 Points; Oracle Shares Spike Higher
Via Benzinga
FedEx Layoffs 2024: What to Know About the Latest FDX Job Cuts
FedEx layoffs will have the delivery company cutting up to 2,000 jobs in Europe as demand for its services are waning after the pandemic. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Dow Surges Over 300 Points; US Inflation Rate Slows In May
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 40% Today?
Tonix Pharmaceuticals stock is down on Wednesday after the company announced a proposed public offering for TNXP shares. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Wednesday morning! 
Via InvestorPlace
Why Oracle Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
Tonix Pharmaceuticals shares are trading lower by 29% during Monday's session. The company effected a 1-for-32 reverse stock split of its common stock. 
Via Benzinga
SOUN Stock Alert: SoundHound AI Pays Off Debt Early
SoundHound AI stock is up on Monday as SOUN investors celebrate the company paying off all of its outstanding debts with cash to spare. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 31% Today?
Tonix Pharmaceuticals stock is down on Monday after shares of TNXP underwent a one-for-32 reverse stock split to avoid delisting. 
Via InvestorPlace
US Stocks Mixed; Perion Network Shares Plunge
Via Benzinga
TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
TNXP stock results show that Tonix Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
3 Biotech Stocks to Dump Before They Go to Zero
These biotech stocks to sell are burning through cash at an alarming rate and seem destined for zero, making them prime targets for selling. 
Via InvestorPlace
TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023
TNXP stock results show that Tonix Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Tonix Pharmaceuticals Stock (TNXP) Hits A New All-Time Low: What's Going On?
Tonix Pharmaceuticals shares are trading lower by 7.2% Monday. The company last week announced the pricing of a $4.4 million registered direct offering. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated
Tonix Pharmaceuticals shares are trading lower by 22.3% Thursday afternoon. The company announced the pricing of a $4.4 million registered direct offering. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of... 
Via Benzinga
3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million
If you want the chance at possible absurd returns, then consider gambling on these stocks to turn $1,000 into $1 million. 
Via InvestorPlace
3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond
When you want to light your afterburners, these ideas will do the trick. 
Via InvestorPlace
Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Getting Patients Addicted In Phase 3 Trial
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and Tonix Pharmaceuticals Holding Corp, a financial partner of Benzinga. The... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.